Literature DB >> 2155509

The replication of viral and cellular DNA in human herpesvirus 6-infected cells.

D Di Luca1, G Katsafanas, E C Schirmer, N Balachandran, N Frenkel.   

Abstract

Human herpesvirus 6 (HHV-6) is a newly identified lymphotropic herpesvirus. We have analyzed viral and host DNA replication in peripheral blood lymphocytes infected in the absence of drugs or infected in the presence of phosphonoacetic acid (PAA) or acyclovir (ACV). The results revealed the following: (i) Infection with HHV-6 resulted in the shutoff of host DNA replication. (ii) PAA at concentrations of 100 and 300 micrograms/ml significantly reduced virus replication. The drug inhibited viral DNA replication, whereas host cell DNA replication was not affected. This strongly suggests that HHV-6 encodes a PAA sensitive viral DNA polymerase. (iii) ACV at 20 microM did not interfere with virus production and virus spread. ACV at 100 microM only partly interfered with virus replication, whereas at 400 microM the block was more complete. Viral DNA replication was not affected by ACV at 20 microM. However, approximately 60 and 85% inhibition in viral DNA replication was observed in the presence of 100 and 400 microM of ACV. (iv) Assays for viral thymidine kinase (TK) revealed no significant increase in TK activity, whereas increased TK activity was noted following infection of the same peripheral blood lymphocytes with herpes simplex virus. Thus, either HHV-6 does not encode a tk enzyme which can phosphorylate ACV or the inefficient block may reflect lower sensitivity of the HHV-6 DNA polymerase to the drug.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2155509     DOI: 10.1016/0042-6822(90)90200-b

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  19 in total

Review 1.  Human herpesvirus 6.

Authors:  D K Braun; G Dominguez; P E Pellett
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Differentiation between two distinct classes of viruses now classified as human herpesvirus 6.

Authors:  E C Schirmer; L S Wyatt; K Yamanishi; W J Rodriguez; N Frenkel
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

3.  Viral glycoproteins accumulate in newly formed annulate lamellae following infection of lymphoid cells by human herpesvirus 6.

Authors:  G Cardinali; M Gentile; M Cirone; C Zompetta; L Frati; A Faggioni; M R Torrisi
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

4.  Temporal mapping of transcripts in herpesvirus 6 variants.

Authors:  P Mirandola; P Menegazzi; S Merighi; T Ravaioli; E Cassai; D Di Luca
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

5.  Human herpesvirus 6B induces cell cycle arrest concomitant with p53 phosphorylation and accumulation in T cells.

Authors:  Bodil Øster; Bettina Bundgaard; Per Höllsberg
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

6.  The DR1 and DR6 first exons of human herpesvirus 6A are not required for virus replication in culture and are deleted in virus stocks that replicate well in T-cell lines.

Authors:  Ronen Borenstein; Haim Zeigerman; Niza Frenkel
Journal:  J Virol       Date:  2010-01-06       Impact factor: 5.103

7.  Quantitative PCR for human herpesviruses 6 and 7.

Authors:  P Secchiero; D Zella; R W Crowley; R C Gallo; P Lusso
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

8.  Human herpesvirus 6 induces interleukin-1 beta and tumor necrosis factor alpha, but not interleukin-6, in peripheral blood mononuclear cell cultures.

Authors:  L Flamand; J Gosselin; M D'Addario; J Hiscott; D V Ablashi; R C Gallo; J Menezes
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

9.  Human herpesvirus 7: antigenic properties and prevalence in children and adults.

Authors:  L S Wyatt; W J Rodriguez; N Balachandran; N Frenkel
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

10.  Human herpesvirus 6A (HHV-6A) and HHV-6B alter E2F1/Rb pathways and E2F1 localization and cause cell cycle arrest in infected T cells.

Authors:  Guy Mlechkovich; Niza Frenkel
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.